What causes tdp 43 aggregation

What Causes TDP-43 Aggregation?

The aggregation of TAR DNA-binding protein 43 (TDP-43) is a complex pathological process that lies at the heart of several devastating neurodegenerative diseases, most notably Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). TDP-43 is a crucial protein that plays a vital role in normal cellular functions, including RNA processing, DNA repair, and gene expression regulation. However, under certain pathological conditions, TDP-43 can misfold and accumulate into insoluble aggregates within neurons, leading to neuronal dysfunction and eventual cell death.

The Role of TDP-43 in the Healthy Brain

In a healthy state, TDP-43 resides primarily in the nucleus of neurons, where it binds to RNA and influences various aspects of RNA metabolism. It is involved in:

• RNA splicing: Modifying how messenger RNA (mRNA) is processed, which dictates which proteins are produced from a gene.
• mRNA stability: Regulating the lifespan of mRNA molecules.
• mRNA transport: Moving mRNA from the nucleus to the cytoplasm, where protein synthesis occurs.
• DNA repair: Participating in the repair of damaged DNA.

This protein is tightly regulated, ensuring it remains in its functional, soluble form and within its normal cellular compartments. When this regulation fails, TDP-43 can become pathogenic.

Mechanisms Leading to TDP-43 Aggregation

The exact triggers for TDP-43 aggregation are still a subject of intense research, but several key factors and mechanisms are understood to contribute:

1. Misfolding and Conformational Changes

Proteins are defined by their specific three-dimensional shapes. Misfolding occurs when a protein deviates from its correct structure. For TDP-43, misfolding can expose hydrophobic regions that are normally tucked away inside the protein. These exposed regions can then interact with similar misfolded TDP-43 molecules, initiating a cascade of self-assembly into larger, insoluble structures known as aggregates or inclusions.

2. Genetic Predisposition

While most cases of ALS and FTD are sporadic (occurring without a clear genetic link), a significant proportion are familial. Specific genetic mutations can dramatically increase the risk of TDP-43 aggregation. For instance:

• C9orf72 gene: This is the most common genetic cause of familial ALS and FTD. Hexanucleotide repeat expansions in this gene are thought to lead to the production of toxic TDP-43 species and potentially disrupt other cellular processes that contribute to aggregation.
• GRN, GRIPE, and SQSTM1 genes: Mutations in these genes are also linked to FTD and ALS and can affect the cellular pathways involved in protein degradation and trafficking, indirectly influencing TDP-43 stability.

Even in sporadic cases, genetic variations (polymorphisms) in genes related to TDP-43 or its regulatory pathways might subtly increase susceptibility to aggregation.

3. Cellular Stress and Dysfunction

Various forms of cellular stress can overwhelm the cell's ability to maintain protein homeostasis, promoting TDP-43 misfolding and aggregation:

• Oxidative Stress: An imbalance between the production of reactive oxygen species (ROS) and the body's ability to detoxify them can damage proteins, including TDP-43, leading to misfolding.
• Mitochondrial Dysfunction: Mitochondria are the powerhouses of the cell. When they are not functioning correctly, cellular energy production is impaired, and ROS production can increase, contributing to overall cellular stress and protein aggregation.
• Endoplasmic Reticulum (ER) Stress: The ER is responsible for protein folding and modification. ER stress, often caused by the accumulation of misfolded proteins, can trigger cellular responses that, if prolonged, can lead to cell death and contribute to TDP-43 pathology.
• Impaired Protein Degradation Pathways: Cells have sophisticated systems, like the ubiquitin-proteasome system (UPS) and autophagy, to clear out damaged or misfolded proteins. If these pathways become less efficient, TDP-43 aggregates have a greater chance of forming and persisting.

4. Ageing

Age is the most significant risk factor for neurodegenerative diseases. As individuals age, cellular repair and maintenance mechanisms naturally decline. This includes a reduced capacity for protein quality control, diminished efficiency of protein degradation pathways, and an increased susceptibility to accumulating cellular damage. These age-related changes create a more permissive environment for proteins like TDP-43 to misfold and aggregate.

5. Post-Translational Modifications

TDP-43 can undergo various chemical modifications after it is synthesized (post-translational modifications or PTMs). These include phosphorylation, ubiquitination, and cleavage. Certain PTMs, particularly hyperphosphorylation, have been strongly associated with the formation of TDP-43 inclusions. These modifications can alter TDP-43's structure, solubility, and interactions with other cellular components, promoting its aggregation.

6. Aberrant Localization

In pathological conditions, TDP-43 can be found mislocalized outside the nucleus, particularly in the cytoplasm. Cytoplasmic TDP-43 is more prone to misfolding and aggregation and can disrupt neuronal function by interfering with RNA granules and other cytoplasmic processes. This mislocalization can be a cause or a consequence of the aggregation process.

Consequences of TDP-43 Aggregation

Once TDP-43 aggregates form, they can exert toxic effects on neurons through several mechanisms:

• Loss of Normal Function: The aggregated TDP-43 is no longer available to perform its essential roles in RNA processing and gene regulation, leading to widespread cellular dysfunction.
• Gain of Toxic Function: The aggregates themselves can be toxic, interfering with cellular machinery, disrupting membrane integrity, and triggering inflammatory responses.
• Impaired Axonal Transport: Aggregates can impede the transport of essential molecules along the neuron's axon, leading to synaptic dysfunction and neuronal death.
• Glial Cell Activation: The presence of protein aggregates can trigger neuroinflammation, activating glial cells (microglia and astrocytes) which, while intended to clear debris, can also contribute to neuronal damage in chronic conditions.

Conclusion

TDP-43 aggregation is a multifaceted pathological process driven by a combination of genetic vulnerability, cellular stress, age-related decline, and specific molecular events like protein misfolding and aberrant PTMs. Understanding these causes is crucial for developing effective therapeutic strategies aimed at preventing or reversing TDP-43 aggregation and treating the debilitating neurodegenerative diseases associated with it.